Report Detail

Request for Sample of this report

Pharma & Healthcare Global Small Nucleic Acid Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4566990
    • |
  • 24 November, 2023
    • |
  • Global
    • |
  • 125 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Small Nucleic Acid Drug market size was valued at USD 4165.3 million in 2022 and is forecast to a readjusted size of USD 15230 million by 2029 with a CAGR of 20.3% during review period.
Small nucleic acid drugs, such as siRNA, ASO, miRNA, Aptamer, etc., function based on the RNAi process and offer various advantages, including unlimited target druggability, high specificity, long half-life, faster and more efficient design, development and production process.
The Small Nucleic Acid Drug Market is driven by the transformative potential of small nucleic acids, including microRNA, aptamers, and small interfering RNA (siRNA), in treating a wide spectrum of diseases, from genetic disorders to cancer and viral infections. These therapies harness the power of small nucleic acids to modulate gene expression, inhibit specific targets, and diagnose diseases, offering a precise and personalized approach to treatment. As genomics and RNA-based research advance, and precision medicine gains prominence, the demand for small nucleic acid drugs continues to surge. Innovations in nucleic acid design, delivery systems, and gene-editing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to overcome hurdles related to safe and efficient drug delivery, minimize off-target effects, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Addressing delivery challenges, optimizing pharmacokinetics, and managing development costs are ongoing hurdles. Additionally, the market faces competition from traditional therapeutic approaches, necessitating continuous research and development efforts to unlock the full therapeutic potential of small nucleic acid drugs. Striking a balance between providing safe, effective, and accessible small nucleic acid therapies while addressing scientific and regulatory challenges is paramount for the continued growth of the Small Nucleic Acid Drug Market.
The Global Info Research report includes an overview of the development of the Small Nucleic Acid Drug industry chain, the market status of Neuromuscular Diseases (Antisense Oligonucleotides (ASO), siRNA), hATTR (Antisense Oligonucleotides (ASO), siRNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Small Nucleic Acid Drug.
Regionally, the report analyzes the Small Nucleic Acid Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Small Nucleic Acid Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Small Nucleic Acid Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Small Nucleic Acid Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antisense Oligonucleotides (ASO), siRNA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Small Nucleic Acid Drug market.
Regional Analysis: The report involves examining the Small Nucleic Acid Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Small Nucleic Acid Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Small Nucleic Acid Drug:
Company Analysis: Report covers individual Small Nucleic Acid Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Small Nucleic Acid Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Neuromuscular Diseases, hATTR).
Technology Analysis: Report covers specific technologies relevant to Small Nucleic Acid Drug. It assesses the current state, advancements, and potential future developments in Small Nucleic Acid Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Small Nucleic Acid Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Small Nucleic Acid Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antisense Oligonucleotides (ASO)
siRNA
Other
Market segment by Application
Neuromuscular Diseases
hATTR
Other
Market segment by players, this report covers
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Small Nucleic Acid Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Nucleic Acid Drug, with revenue, gross margin and global market share of Small Nucleic Acid Drug from 2018 to 2023.
Chapter 3, the Small Nucleic Acid Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Small Nucleic Acid Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Nucleic Acid Drug.
Chapter 13, to describe Small Nucleic Acid Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Small Nucleic Acid Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Small Nucleic Acid Drug by Type
    • 1.3.1 Overview: Global Small Nucleic Acid Drug Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Small Nucleic Acid Drug Consumption Value Market Share by Type in 2022
    • 1.3.3 Antisense Oligonucleotides (ASO)
    • 1.3.4 siRNA
    • 1.3.5 Other
  • 1.4 Global Small Nucleic Acid Drug Market by Application
    • 1.4.1 Overview: Global Small Nucleic Acid Drug Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Neuromuscular Diseases
    • 1.4.3 hATTR
    • 1.4.4 Other
  • 1.5 Global Small Nucleic Acid Drug Market Size & Forecast
  • 1.6 Global Small Nucleic Acid Drug Market Size and Forecast by Region
    • 1.6.1 Global Small Nucleic Acid Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Small Nucleic Acid Drug Market Size by Region, (2018-2029)
    • 1.6.3 North America Small Nucleic Acid Drug Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Small Nucleic Acid Drug Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Small Nucleic Acid Drug Market Size and Prospect (2018-2029)
    • 1.6.6 South America Small Nucleic Acid Drug Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Small Nucleic Acid Drug Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Sarepta Therapeutics
    • 2.1.1 Sarepta Therapeutics Details
    • 2.1.2 Sarepta Therapeutics Major Business
    • 2.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Product and Solutions
    • 2.1.4 Sarepta Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sarepta Therapeutics Recent Developments and Future Plans
  • 2.2 Ionis Pharmaceuticals
    • 2.2.1 Ionis Pharmaceuticals Details
    • 2.2.2 Ionis Pharmaceuticals Major Business
    • 2.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Product and Solutions
    • 2.2.4 Ionis Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Ionis Pharmaceuticals Recent Developments and Future Plans
  • 2.3 Alnylam
    • 2.3.1 Alnylam Details
    • 2.3.2 Alnylam Major Business
    • 2.3.3 Alnylam Small Nucleic Acid Drug Product and Solutions
    • 2.3.4 Alnylam Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Alnylam Recent Developments and Future Plans
  • 2.4 Biogen
    • 2.4.1 Biogen Details
    • 2.4.2 Biogen Major Business
    • 2.4.3 Biogen Small Nucleic Acid Drug Product and Solutions
    • 2.4.4 Biogen Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Biogen Recent Developments and Future Plans
  • 2.5 Nippon Shinyaku
    • 2.5.1 Nippon Shinyaku Details
    • 2.5.2 Nippon Shinyaku Major Business
    • 2.5.3 Nippon Shinyaku Small Nucleic Acid Drug Product and Solutions
    • 2.5.4 Nippon Shinyaku Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Nippon Shinyaku Recent Developments and Future Plans
  • 2.6 Sobi
    • 2.6.1 Sobi Details
    • 2.6.2 Sobi Major Business
    • 2.6.3 Sobi Small Nucleic Acid Drug Product and Solutions
    • 2.6.4 Sobi Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Sobi Recent Developments and Future Plans
  • 2.7 Novartis
    • 2.7.1 Novartis Details
    • 2.7.2 Novartis Major Business
    • 2.7.3 Novartis Small Nucleic Acid Drug Product and Solutions
    • 2.7.4 Novartis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Novartis Recent Developments and Future Plans
  • 2.8 Jazz Pharmaceuticals
    • 2.8.1 Jazz Pharmaceuticals Details
    • 2.8.2 Jazz Pharmaceuticals Major Business
    • 2.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Product and Solutions
    • 2.8.4 Jazz Pharmaceuticals Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Jazz Pharmaceuticals Recent Developments and Future Plans
  • 2.9 CureVac
    • 2.9.1 CureVac Details
    • 2.9.2 CureVac Major Business
    • 2.9.3 CureVac Small Nucleic Acid Drug Product and Solutions
    • 2.9.4 CureVac Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 CureVac Recent Developments and Future Plans
  • 2.10 Regulus Therapeutics
    • 2.10.1 Regulus Therapeutics Details
    • 2.10.2 Regulus Therapeutics Major Business
    • 2.10.3 Regulus Therapeutics Small Nucleic Acid Drug Product and Solutions
    • 2.10.4 Regulus Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Regulus Therapeutics Recent Developments and Future Plans
  • 2.11 ProQR
    • 2.11.1 ProQR Details
    • 2.11.2 ProQR Major Business
    • 2.11.3 ProQR Small Nucleic Acid Drug Product and Solutions
    • 2.11.4 ProQR Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 ProQR Recent Developments and Future Plans
  • 2.12 Secarna
    • 2.12.1 Secarna Details
    • 2.12.2 Secarna Major Business
    • 2.12.3 Secarna Small Nucleic Acid Drug Product and Solutions
    • 2.12.4 Secarna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Secarna Recent Developments and Future Plans
  • 2.13 MiNA Therapeutics
    • 2.13.1 MiNA Therapeutics Details
    • 2.13.2 MiNA Therapeutics Major Business
    • 2.13.3 MiNA Therapeutics Small Nucleic Acid Drug Product and Solutions
    • 2.13.4 MiNA Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 MiNA Therapeutics Recent Developments and Future Plans
  • 2.14 Sylentis
    • 2.14.1 Sylentis Details
    • 2.14.2 Sylentis Major Business
    • 2.14.3 Sylentis Small Nucleic Acid Drug Product and Solutions
    • 2.14.4 Sylentis Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Sylentis Recent Developments and Future Plans
  • 2.15 Arrowhead
    • 2.15.1 Arrowhead Details
    • 2.15.2 Arrowhead Major Business
    • 2.15.3 Arrowhead Small Nucleic Acid Drug Product and Solutions
    • 2.15.4 Arrowhead Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Arrowhead Recent Developments and Future Plans
  • 2.16 Silence Therapeutics
    • 2.16.1 Silence Therapeutics Details
    • 2.16.2 Silence Therapeutics Major Business
    • 2.16.3 Silence Therapeutics Small Nucleic Acid Drug Product and Solutions
    • 2.16.4 Silence Therapeutics Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Silence Therapeutics Recent Developments and Future Plans
  • 2.17 Dicerna
    • 2.17.1 Dicerna Details
    • 2.17.2 Dicerna Major Business
    • 2.17.3 Dicerna Small Nucleic Acid Drug Product and Solutions
    • 2.17.4 Dicerna Small Nucleic Acid Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Dicerna Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Small Nucleic Acid Drug Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Small Nucleic Acid Drug by Company Revenue
    • 3.2.2 Top 3 Small Nucleic Acid Drug Players Market Share in 2022
    • 3.2.3 Top 6 Small Nucleic Acid Drug Players Market Share in 2022
  • 3.3 Small Nucleic Acid Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Small Nucleic Acid Drug Market: Region Footprint
    • 3.3.2 Small Nucleic Acid Drug Market: Company Product Type Footprint
    • 3.3.3 Small Nucleic Acid Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Small Nucleic Acid Drug Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Small Nucleic Acid Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Small Nucleic Acid Drug Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Small Nucleic Acid Drug Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Small Nucleic Acid Drug Consumption Value by Type (2018-2029)
  • 6.2 North America Small Nucleic Acid Drug Consumption Value by Application (2018-2029)
  • 6.3 North America Small Nucleic Acid Drug Market Size by Country
    • 6.3.1 North America Small Nucleic Acid Drug Consumption Value by Country (2018-2029)
    • 6.3.2 United States Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Small Nucleic Acid Drug Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Small Nucleic Acid Drug Consumption Value by Type (2018-2029)
  • 7.2 Europe Small Nucleic Acid Drug Consumption Value by Application (2018-2029)
  • 7.3 Europe Small Nucleic Acid Drug Market Size by Country
    • 7.3.1 Europe Small Nucleic Acid Drug Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 7.3.3 France Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Small Nucleic Acid Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Small Nucleic Acid Drug Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Small Nucleic Acid Drug Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Small Nucleic Acid Drug Market Size by Region
    • 8.3.1 Asia-Pacific Small Nucleic Acid Drug Consumption Value by Region (2018-2029)
    • 8.3.2 China Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 8.3.5 India Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Small Nucleic Acid Drug Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Small Nucleic Acid Drug Consumption Value by Type (2018-2029)
  • 9.2 South America Small Nucleic Acid Drug Consumption Value by Application (2018-2029)
  • 9.3 South America Small Nucleic Acid Drug Market Size by Country
    • 9.3.1 South America Small Nucleic Acid Drug Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Small Nucleic Acid Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Small Nucleic Acid Drug Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Small Nucleic Acid Drug Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Small Nucleic Acid Drug Market Size by Country
    • 10.3.1 Middle East & Africa Small Nucleic Acid Drug Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Small Nucleic Acid Drug Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Small Nucleic Acid Drug Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Small Nucleic Acid Drug Market Drivers
  • 11.2 Small Nucleic Acid Drug Market Restraints
  • 11.3 Small Nucleic Acid Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Small Nucleic Acid Drug Industry Chain
  • 12.2 Small Nucleic Acid Drug Upstream Analysis
  • 12.3 Small Nucleic Acid Drug Midstream Analysis
  • 12.4 Small Nucleic Acid Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Small Nucleic Acid Drug. Industry analysis & Market Report on Small Nucleic Acid Drug is a syndicated market report, published as Global Small Nucleic Acid Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Small Nucleic Acid Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo